Report Highlights
- Global sales of autacoids and related drugs reached $94.6 billion in 2009. The market is expected to rise at a compound annual growth rate (CAGR) of 3.2% to reach $112.6 billion by 2015.
The autacoids market is dominated by biogenic amines, with revenues of $62.9 billion in 2009, and similar expected revenues in 2010. This market is projected to rise at a compound annual growth rate (CAGR) of 2.5% and reach $71.1 billion by 2015. - The second-largest category of autacoids-related drugs is polypeptide autacoids, which generated $20.1 billion in 2009 and are projected to generate $24.9 billion by 2015, for a compound annual growth rate (CAGR) of 3.3%.
INTRODUCTION
STUDY OBJECTIVES
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for autacoids and related products. The key objective is to present a comprehensive analysis of the current market for autacoids and related drugs and its future direction, and to examine the x biologic activity and usage of autacoids in the treatment of various diseases.
This report explores present and future strategies within the autacoids and related drug market, including the biogenic amines, polypeptide derivatives, lipid-derived autacoids, and endothelium-derived autacoids. Market requirements and setbacks in efforts of improvisation are discussed. An overview of autacoids and related products forms the background of this report.
A detailed analysis of the structure of commerce in autacoids and related products has been conducted. This includes all four major categories of autacoid-related products, further divided into subcategories. Revenues are broken down by region and subcategories. Sales figures are estimated for the 5-year period from 2010 through 2015.
Applications for autacoids and related products utilizing their theraputic benefits are also discussed separately in the report, with emphasis on results in respiratory, cardiovascular, CNS, analgesics, antiemetics, et al. The report also covers significant patents and their allotments in each category.
REASONS FOR DOING THIS STUDY
This study was conducted to give insight into, and to categorize autacoids and related products. The industry is undergoing a transition due to generics hitting the market and other new developments. This study was conducted to provide detailed market analysis of autacoids and related products along with the factors affecting this market. As did many industries, autacoids experienced setbacks in 2009 due to the economic downturn as well as patent expirations, but some new advances may influence market growth. This study examines systemic influences in the autacoid market landscape.
Acquisition strategies and collaborations by companies are covered in this report. BCC also discusses the strengths and weaknesses of each category of the market in light of the new technologies/developments, growing competition, and changing customer needs.
INTENDED AUDIENCE
This study delves into the areas of market growth as well as decline in certain categories of autacoids and related products from the point of view of manufacturers and users. Analytical companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals, and research institutes will all find this study to be of interest.
SCOPE OF THE STUDY
The scope of this study encompasses the autacoid-related product manufacturers and various therapeutic medical markets. BCC analyzes each market and its applications by reviewing its regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.
METHODOLOGY
BCC conducted a comprehensive literature search that included technical newsletters and journals, and numerous other sources. Data were collected through interviews and correspondence with various analytical/chemical/pharmaceutical/biotechnical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.
INFORMATION SOURCES
Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers as well as end users of autacoids and related products. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.
ABOUT THE AUTHOR
Shalini S Dewan holds a master’s degree in pharmaceutical chemistry. Among the research topics she has covered are studies on compounds from ibuprofen and 2-naphthyl acetic acid that are of potential pharmaceutical interest. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are Reagents for Chromatography; Spectroscopy, An Enduring Market; Advanced Drug Delivery Systems: New Developments, New Technologies; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; and The Dynamic Media, Sera and Reagent Market in Biotechnology.
BCC ONLINE SERVICES
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers
DISCLAIMER
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.
Related Reports
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Brain Tumor Therapeutics: Global Markets to 2030
The report provides an analysis of brain tumor therapeutics and analyzes market trends. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030. The market in this report is segmented by therapy type, patient age, end user, and region. The report covers regulatory scenarios, drivers, restraints, opportunities, and the market share for key companies.
Global Viral Vector Manufacturing Markets and Technologies Through 2030
The global market for viral vector manufacturing is expected to grow from $6.3 billion in 2025 and is projected to reach $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 24.6% during the forecast period of 2025 to 2030.
Hyaluronic Acid in Healthcare: Global Markets
The global market for hyaluronic acid medical products is estimated to grow from $8 billion in 2025 to $10.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2030.
Targeted Alpha Therapies for Cancer Treatment: Global Market
This report provides an overview of the global market for targeted alpha therapies for cancer and analyses market trends. It includes global revenue ($ millions) for the base year data 2024 and estimated data for 2025, forecasted CAGRs through 2030.
Therapies for Rheumatoid Arthritis: Technologies and Global Markets
The global market for rheumatoid arthritis therapies was valued at $28.5 billion in 2024 and is estimated to increase from $30.2 billion in 2025 to reach $41.1 billion by 2030, at a compound annual growth rate (CAGR) of 6.3% from 2025 through 2030.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More